By Tony DeSpirito Markets tend to focus on one risk at a time, and its fragile U.S.-China relations that are front and center now. New blog contributor Tony DeSpirito offers up two potential takeaways...
Canntab Therapeutics Ltd.
We have developed a product line of solid oral dose delivery systems including extended release (XR), flash melt, immediate release, modified release and bi-layered tablet solutions that provide a variety of cannabinoid and terpenoid blends in exacting dosages. A clear and sustainable competitive advantage with 13 patents pending.
1d
5d
1m
6m
1y
Max
Canntab Therapeutics Ltd. News
Direxion, one of the largest issuers of leveraged exchange traded funds, is planning to change the indexes its leveraged pharmaceuticals and real estate ETFs track. Currently, the Direxion Daily Pharmaceutical...
NEW YORK , May 31, 2019 /PRNewswire/ -- The Board of Trustees of the Direxion Shares ETF Trust ("Trust") has approved changes to the investment objective, investment strategy and underlying index of...
23 May
Volatility 101: Should Canntab Therapeutics (CNSX:PILL) Shares Have Dropped 11%?
The simplest way to benefit from a rising market is to buy an index fund. While individual stocks can be big winners...
Top gainers: CURE +10.4% . PILL +9.7% . LABU +8.2% . YANG +7.9% . UBIO +7.1% . More news on: Direxion Daily Healthcare Bull 3x Shares ETF, Direxion Daily Pharmaceutical & Medical Bull 3X...
Big pharmaceutical companies were on the hot seat at Capitol Hill today with CVS Health, Cigna, Prime Therapeutics, Humana, and UnitedHealthcare's OptumRx testifying before the Senate Finance Committee...
The Daily Pharmaceutical & Medical Bull 3X Shares (PILL) gained 1.35 percent on news that General Electric will sell its biopharmaceutical business to conglomerate company Danaher for $21.4 billion....
According to a report by the Silicon Valley Bank, biopharma deals in 2018 totaled $49 billion and more mergers in 2019 could continue providing growth in the industry, fueling ETFs like Daily Pharmaceutical...
Healthcare ETFs have been displaying positive momentum. Traders looking to bolster that healthcare momentum profile can consider leveraged ETFs, such as the Direxion Daily Pharmaceutical & Medical Bull...
With markets jittery about tariffs and trade wars, investors considering sector-level ideas may want to lean toward groups that generate significant portions of their revenue on a domestic basis. The healthcare...
About Canntab Therapeutics Ltd.
Working with Emblem Corp. in Canada and leveraging our joint venture with Cann Global Limited to market in Australia and Asia, Canntab Therapeutics will be perfectly positioned in the growing wellness market. Two of our products having already received an NPN number from Health Canada. With the help of Lorne Gertner and other we intend to open up markets around the world and as Mr. Gertner says,
“I believe the ultimate solution to the delivery of Cannabis will be through a hard pill.”
We understand the growing cannabis health and wellness market and are positioned as the premier solution for medical oral dose administration. Safe, discreet, accurate and reliable. Lead by a team of professionals with the experience needed to bring these products to market.
$ 7.49
-0.53%
Open:
7.64
High:
7.72
Low:
7.47
Market cap:
13.219 M
Symbol:
PILL
Contact info
Phone:
4169963762
Address:
223 Riviera Dr, Markham, ON L3R 5J6, Canada
